Zonsen PepLib – Talk Bio

Actionable Insights Powered by AI

Novartis Licenses Undisclosed Radioligand Therapy Asset from China’s Zonsen PepLib Biotech

Novartis; Zonsen PepLib; radiopharma; radioligand therapy; licensing deal; China biotech